Award
Delivery Order #SPE2DR26FDK9L
Pharmaceutical Delivery Order for Celecoxib Capsules to Support Federal Supply Chain
Buyer
Defense Logistics Agency
Award Amount
$106.95
Ceiling
$106.95
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FDK9L
NAICS
424210
This contract is a delivery order under an indefinite delivery vehicle (IDV) previously awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical sourcing and distribution company. The order procures Celecoxib 100 mg capsules, reflecting the agency's ongoing need to secure critical medications for healthcare services. The significance of this award lies in maintaining timely access to essential pharmaceutical products within the federal supply chain, ensuring continuity and reliability in medication availability. The scope covers procurement and delivery of the specified pharmaceutical capsules with prompt performance over a short timeframe. The delivery order builds upon the parent IDV contract that supports federal pharmaceutical supply from 2025 through 2036. While this delivery order focuses on a specific product and has a brief performance period, it aligns with the overarching strategy for consistent medication provisioning. The award follows the established IDV contract vehicle; information about competitive bidding or subcontractors for this particular order is not available. The contract performance is set for a concise period in early 2026, ensuring swift delivery.
Description
4571117392!CELECOXIB 100 MG CAPSULE 500S